Skip to main content
Premium Trial:

Request an Annual Quote

Thermo Fisher, Premier Biosoft Ink Co-marketing Agreement


Thermo Fisher Scientific and Premier Biosoft have agreed to co-market Premier's SimGlycan software.

SimGlycan is a glycan and glycopeptide tandem mass spectrometry data analysis tool that includes an additional module for validating structures identified using multi stage/sequential mass spectrometry.

The software is designed for use with a number of Thermo's Orbitrap and ion trap mass spectrometers.

In a statement, Andreas Hunter said that the agreement enables Thermo to offer an "integrated solution" for characterizing glycans, which are oligosaccharide or polysaccharide molecules found attached to proteins and lipids that can be used as markers for disease.

Kay Brown, Premier's president, said that partnering with Thermo provides her firm an opportunity to leverage a "broader sales and marketing channel" to reach its target customer base.

The Scan

Not Immediately Told

The US National Institutes of Health tells lawmakers that one of its grantees did not immediately report that it had developed a more infectious coronavirus, Science says.

Seems Effective in Kids

The Associated Press reports that the Pfizer-BioNTech SARS-CoV-2 vaccine for children appears to be highly effective at preventing symptomatic disease.

Intelligence Warning on Bioeconomy Threats

US intelligence warns over China's focus on technologies and data related to the bioeconomy, the New York Times reports.

PLOS Papers on Campylobacteriosis Sources, Inherited Retinal Dystrophies, Liver Cancer Prognosis

In PLOS this week: approach to uncover source of Campylobacteriosis, genetic risk factors for inherited retinal dystrophies, and more.